Mohammad Abdullah Taher

Mohammad Abdullah Taher

Auto-generated profile, based on publicly available information

Mohammad Abdullah Taher

Affiliations Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Phytochemical Research Laboratory, University of Dhaka, Dhaka, Bangladesh, Bangladesh Reference Institute for Chemical Measurements (BRiCM), Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
PJPair Ahmed Jiko
Pair Ahmed Jiko
MMMahathir Mohammad
Mahathir Mohammad
FRFahmida Tasnim Richi
Fahmida Tasnim Richi
AIAnisul Islam
Anisul Islam
Safaet AlamSafaet Alam
Safaet Alam
AMAbdullah Al Mamun
Abdullah Al Mamun
Background: Shirakiopsis indica (Willd)., commonly known as Sa-Mor-Ta-Lay in Thailand, is a mangrove plant belonging to the Euphorbiaceae family. As mangrove plants’ medicinal potentials are less explored, this study sought to qualitatively and quantitatively verify the bioactive components of Shirakiopsis indica fruits methanolic extract (SIF-ME) at the side of its analgesic, anti-inflammatory and anti-oxidant effects followed by in-silico studies. Methods: The in-vivo assessments of analgesic activity involved the hot plate test, acetic acid-induced writhing test, and formalin-induced licking test. The anti-inflammatory efficacy was assessed through the human RBC membrane stabilization assay (HRBC), protein denaturation assay, and xylene-induced ear edema methods. Antioxidant potential was implemented by the DPPH scavenging method. Results: The SIF-ME consistently displayed significant anti-nociceptive activity in a dose-dependent pattern (p < 0.05). The maximum analgesic activity was found in the highest dose (200 mg/kg; p < 0.001) in a hot plate, acetic acid-induced writhing test 43.47%, and in formalin-induced licking test in both early phase (43.3%; p < 0.01) and late phase (61.84%; p < 0.001%). The extract provided optimal protection against hemolysis (83.41% decrease) at 1000 μg/mL and significantly inhibited protein denaturation (67.34– 26.05%) at doses of 1000– 62.5 μg/mL. At 200 mg/kg, the extract showed dose-dependent and substantial inhibition (54.07%; p < 0.01) of xylene-induced ear edema. The in-vitro DPPH (IC50 = 469.5 μg/mL) results showed remarkable scavenging activity and concentration-dependent reducing power. The extract demonstrates no acute oral toxicity, as indicated by an LD50 value exceeding 1000 mg/kg body weight. Gas Chromatography-Mass Spectrometry/Mass Spectrometry (GC-MS/MS) analysis was performed which yielded sixty bioactive compounds. In-silico and molecular docking studies revealed favorable pharmacological properties, including good binding affinities and ADME/T profiles. Conclusion: These results support the medicinal use of the plant, which makes it a potential source of analgesic, anti-inflammatory, and antioxidant candidates.

27 March 2024 in Heliyon
Verified
Journal Article
Open access
MTMohammad Abdullah Taher
Mohammad Abdullah Taher
ALAysha Akter Laboni
Aysha Akter Laboni
AIAshraful Islam
Ashraful Islam
HHHasin Hasnat
Hasin Hasnat
MHMohammad Mahmudul Hasan
Mohammad Mahmudul Hasan
MKMala Khan
Mala Khan
The purpose of the current investigation was to conduct a detailed analysis of the chemical components and medicinal properties of the methanolic crude extract derived from the leaves of Cassia fistula. This analysis was carried out using both experimental (in vivo) and computational (in silico) methods. Eleven chemicals were chromatographically isolated using GC-MS/MS, which utilizes a library of NIST and Wiley 2020 versions. FTIR analysis of the extract was performed to identify the functional group of the compounds. The glucose-lowering capacity, analgesic, and anti-diarrheal activities of methanolic crude extract were analyzed utilizing a well-known oral glucose tolerance test, tail immersion method, writhing assay, and castor oil-induced diarrheal mice methods, respectively. After 60 min, 120 min, and 180 min of loading the drugs, a significant reduction of blood glucose levels was examined (p < 0.05) in all the extracts of this plant (200 mg/kg, 400 mg/kg and 600 mg/kg) utilized in this research at a time-dependent manner. Similarly, all the crude extracts showed significant (p < 0.05) effects against pain centrally and peripherally compared to the standard drug morphine (2 mg/kg bw) and diclofenac sodium (50 mg/kg bw). Moreover, the methanol extract (400 mg/kg bw) manifested anti-diarrheal efficacy by inhibiting 72.0 % of the diarrheal episode in mice compared to the standard drug loperamide (inhibition = 80.0%). The results of the computational investigations corroborated existing in-vivo findings. Greater or close to equivalent binding affinity to the active binding sites of kappa opioid receptor, glucose transporter 3 (GLUT 3), and cyclooxygenase 2 was indicative of the potential anti-diarrheal, hypoglycemic, and analgesic characteristics of the isolated compounds (COX-2). Moreover, anticancer and antimicrobial potentiality was also found impressive through evaluation of binding affinity with epidermal growth factor receptor (EGFR) and dihydrofolate reductase (DHFR) receptors. Results from this study indicated that C. fistula might be a beneficial natural resource for treating diarrhea, hyperglycemia, and pain. However, additional research is required to conduct a comprehensive phytochemical screening and establish precise action mechanisms of the crude extract or the plant-derived compounds.

12 September 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMohammad Abdullah Taher
Mohammad Abdullah Taher
AIAshraful Islam
Ashraful Islam
STSalsabil Fatima Tasmi
Salsabil Fatima Tasmi
MHMohammad Mahmudul Hasan
Mohammad Mahmudul Hasan
HHHasin Hasnat
Hasin Hasnat
MKMala Khan
Mala Khan
The increasing threat of antimicrobial resistance and the need for new medicines have renewed interest in medicinal plants like Moringa oleifera Lam., a fast-growing tree from the Moringaceae family that can survive in dry conditions. It is easily recognized by its compound leaves and long seed pods. Traditionally, it has been widely used in Ayurvedic medicine and as a nutrient-rich food source, with its leaves, pods, and seeds employed for treating malnutrition, inflammation, and over 300 ailments across South Asia and Africa. A methanolic leaf extract was prepared and analyzed via GC-MS/MS for phytoconstituents. Antimicrobial activity was tested against Gram-positive, Gram-negative bacteria, and fungi using disc diffusion (100 µg/disc), compared to standard antibiotics (30 µg/disc). Antidiarrheal (castor oil-induced model) and analgesic (acetic acid-induced writhing) effects were assessed at 200 and 400 mg/kg doses, with Loperamide and Diclofenac as standards, respectively. Molecular docking analyzed interactions of key compounds with therapeutic targets (URO, EGFR, DHFR, etc.). GC-MS/MS revealed 79 bioactive compounds including 4,5-dimethoxy-2-biphenylcarboxylic acid (14.32%), gamma-sitosterol (3.83%) and stigmasterol (0.81%). The extract showed broad-spectrum antibacterial activity, with strongest inhibition against Pseudomonas aeruginosa (19 mm) and Salmonella typhi (19 mm), though 30–50% less potent than standard antibiotics. In antidiarrheal testing, 400 mg/kg dose reduced diarrheal episodes by 58.06% compared to control, while in analgesic assay it decreased writhing by 59.18%. Molecular docking demonstrated superior binding of compounds 57, 65 and 61 to molecular targets, with compound 57 showing strongest affinity to URO (−6.7 kcal/mol) and compound 65 to EGFR (−9.6 kcal/mol). ADME/T analysis revealed compounds C57, C59 and C61 possessed optimal drug-likeness (log P 1.33–3.02), high GI absorption, and no predicted toxicity – contrasting with poorly absorbed compounds (C13, C28; TPSA>150). Moringa oleifera methanolic leaves extract demonstrated broad-spectrum bioactivity, validating its traditional uses. While less potent than synthetic drugs, its multi-target mechanisms and bioactive diversity highlight its potential as an adjunct therapy. Further studies should isolate active compounds and optimize formulations for clinical applications.

25 September 2024 in Health Science Reports
Verified
Journal Article
Open access
MTMohammad Abdullah Taher
Mohammad Abdullah Taher
RKRipa Kundu
Ripa Kundu
ALAysha Akter Laboni
Aysha Akter Laboni
SSSuriya Akter Shompa
Suriya Akter Shompa
MOMoniruzzaman
Moniruzzaman
MKMala Khan
Mala Khan
Background and aims: This study investigated the biochemical components present in the leaves of Cissus assamica. The primary aim was to analyze these components using advanced techniques and assess their potential therapeutic applications.Methodology: Fourier Transform Infrared (FT‐IR) spectroscopy, Gas Chromatography‐Mass Spectrometry (GC‐MS), and Mass Spectral analysis were employed to identify and characterize the compounds in Cissus assamica leaves. The mass spectra of each compound were compared with data from the Wiley and NIST libraries to determine their names, molecular masses, and chemical structures. FT‐IR analysis identified characteristic functional groups by their specific frequencies.Results and discussion: FT‐IR spectroscopic analysis revealed significant molecular vibrations at frequencies of 3265.63, 2853.81, 1638.60, 1469.21, and 1384.95 cm⁻¹, indicating the presence of specific functional groups. The GC‐MS analysis identified distinct compounds, such as “aR‐Turmerone,” “Curlone,” “7,8‐Epoxylanostan‐11‐ol, 3‐acetoxy‐,” “13‐Docosenamide, (Z)‐,” “Phenol, 3,5‐bis(1,1‐dimethylethyl)‐,” “9,19‐Cyclolanostan‐3‐ol, 24,24‐epoxymethano‐, acetate,” and “Quinoline‐5,8‐dione‐6‐ol, 7‐[[(4‐cyclohexylbutyl)amino]methyl]‐.” These compounds exhibited potential therapeutic applications. Their cytotoxic, antimicrobial, antidiarrheal, anti‐hyperglycemic, and pain‐relieving properties were evaluated by comparing them with reference ligands targeting specific receptors, including dihydrofolate reductase (DHFR), epidermal growth factor receptor (EGFR), kappa opioid receptor (KOR), glucose transporter 3 (GLUT 3), and cyclooxygenase 2 (COX‐2).Conclusion: The results of this study suggest that Cissus assamica leaves contain bioactive compounds with potential therapeutic benefits for treating infections, diarrhea, hyperglycemia, and pain. However, further research is needed to conduct comprehensive phytochemical screening and establish the precise mechanisms of action for the crude extract or the plant‐derived compounds.

18 May 2021 in International Journal of Medicine and Medical Research
Verified
Journal Article
Open access
PDF file
APA. A. H. Pinkey
A. A. H. Pinkey
MKMd Zahirul ISLAM KHAN
Md Zahirul ISLAM KHAN
MTM. A. Taher
M. A. Taher
MSM. A. Soma
M. A. Soma
Background. Elaeocarpus serratus L. (Family: Elaeocarpaceae) is a tropical fruit tree, traditionally used in the treatments of poisoning, diarrhea, arthritis, and other diseases. Objectives. The current study was performed to conduct the analgesic, antidiarrheal, and hypoglycemic activity of E. serratus in mice model using methanolic bark crude extract. Methods. To assess the peripheral and central analgesic activity, the acetic acid-induced writhing and tail immersion methods were respectively used. The castor-oil mediated antidiarrheal method was used to assess the antidiarrheal activity whereas, the tail tipping technique was conducted to determine the hypoglycemic activity of the plant extract. Results. In the peripheral analgesic assay, the methanolic bark crude extract of E. serratus significantly inhibits the number of writing 69.77% (200 mg/kg) and 73.26% (400 mg/kg) respectively (p<0.05) which was strongly comparable with standard NSAID drug diclofenac sodium 75.58% (p<0.05). Similarly, it shown a significant tail flicking response for 30 minutes, 60 minutes and 90 minutes of central analgesic activity assay. In antidiarrheal activity assay, the E. serratus substantially reduced the number of diarrheal feces 64.26% (200 mg/kg, p<0.05) and 78.57% (400 mg/kg, p<0.05) which was also comparable with the positive control loperamide. The hypoglycemic activity of E. serratus extract was not convincing. Conclusions. Our investigation demonstrated the significant analgesic and antidiarrheal activities of methanolic bark extract of E. serratus (200 and 400 mg/kg) in mice model.

4 February 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
Safaet AlamSafaet Alam
Safaet Alam
NCNafees Rahman Chowdhury
Nafees Rahman Chowdhury
AHAbir Hossain
Abir Hossain
FRFahmida Tasnim Richi
Fahmida Tasnim Richi
Nazim Uddin EmonNazim Uddin Emon
Nazim Uddin Emon
MTMohammad Abdullah Taher
Mohammad Abdullah Taher